BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32342618)

  • 1. Transplant-associated cancer in the era of immune checkpoint inhibitors: Primum non nocere.
    Zwald FO
    Am J Transplant; 2020 Sep; 20(9):2299-2300. PubMed ID: 32342618
    [No Abstract]   [Full Text] [Related]  

  • 2. A Call to Action: The Need for Improved Transplant Cancer Screening Guidelines.
    Blosser CD
    Am J Transplant; 2017 Jan; 17(1):9-10. PubMed ID: 27589841
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer immunotherapy in a neglected population: The current use and future of T-cell-mediated checkpoint inhibitors in organ transplant patients.
    Chae YK; Galvez C; Anker JF; Iams WT; Bhave M
    Cancer Treat Rev; 2018 Feb; 63():116-121. PubMed ID: 29276997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for Solid Organ Transplantation for Transplant Candidates With a Pretransplant Diagnosis of Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma and Melanoma: A Consensus Opinion From the International Transplant Skin Cancer Collaborative (ITSCC).
    Zwald F; Leitenberger J; Zeitouni N; Soon S; Brewer J; Arron S; Bordeaux J; Chung C; Abdelmalek M; Billingsley E; Vidimos A; Stasko T
    Am J Transplant; 2016 Feb; 16(2):407-13. PubMed ID: 26820755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer in Solid Organ Transplant Recipients: There Is Still Much to Learn and Do.
    Engels EA
    Am J Transplant; 2017 Aug; 17(8):1967-1969. PubMed ID: 28394489
    [No Abstract]   [Full Text] [Related]  

  • 6. Quality metrics in transplantation - A new emphasis on transplant access.
    Patzer RE
    Am J Transplant; 2018 Jun; 18(6):1301-1302. PubMed ID: 29633579
    [No Abstract]   [Full Text] [Related]  

  • 7. Primum non nocere (first, or above all, do no harm).
    Berlet GC
    Foot Ankle Spec; 2009 Oct; 2(5):213. PubMed ID: 19825775
    [No Abstract]   [Full Text] [Related]  

  • 8. Accelerated Use of Non-Surgical Techniques for Nevi Removal: Primum Non-Nocere.
    Vural S; Akay BN; Yaycıoğlu A; Bostancı S
    Dermatol Pract Concept; 2021 Sep; 11(4):e2021117. PubMed ID: 34631266
    [No Abstract]   [Full Text] [Related]  

  • 9. Board certification in transplant pharmacotherapy.
    Zavala EY
    Am J Transplant; 2018 Sep; 18(9):2372. PubMed ID: 29981204
    [No Abstract]   [Full Text] [Related]  

  • 10. FcγRIIB, a new checkpoint to halt alloreactive memory T cells.
    Cravedi P
    Am J Transplant; 2020 Aug; 20(8):1967-1968. PubMed ID: 32185851
    [No Abstract]   [Full Text] [Related]  

  • 11. C4: The future of solid organ transplantation from the perspective of young transplant professionals.
    Benjamens S; van den Berg TAJ; Pol RA
    Am J Transplant; 2019 Jun; 19(6):1867. PubMed ID: 30548561
    [No Abstract]   [Full Text] [Related]  

  • 12. Ipilimumab for the treatment of advanced melanoma in six kidney transplant patients.
    Zehou O; Leibler C; Arnault JP; Sayegh J; Montaudié H; Rémy P; Glotz D; Cordonnier C; Martin L; Lebbé C
    Am J Transplant; 2018 Dec; 18(12):3065-3071. PubMed ID: 30107088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune checkpoint inhibitors in the management of malignancies in transplant recipients.
    Regalla DKR; Williams GR; Paluri RK
    Postgrad Med J; 2018 Dec; 94(1118):704-708. PubMed ID: 30425139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: Population-based cohort study.
    Chan AW; Fung K; Austin PC; Kim SJ; Singer LG; Baxter NN; Alhusayen R; Rochon PA
    Am J Transplant; 2019 Feb; 19(2):522-531. PubMed ID: 29900669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The best transplant strategy? It depends.
    Manook M; Kirk AD
    Am J Transplant; 2020 May; 20(5):1221-1222. PubMed ID: 32037643
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune checkpoint inhibitors in melanoma.
    Carlino MS; Larkin J; Long GV
    Lancet; 2021 Sep; 398(10304):1002-1014. PubMed ID: 34509219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A caveat to the MISSION Act: Perspective from a Veterans Administration transplant center.
    Lockridge J; Norman D; Rehman S; Scott D; Maynard E; Bowers D; Siegman I; Martin K
    Am J Transplant; 2019 Nov; 19(11):3210-3211. PubMed ID: 31325351
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: A systematic review.
    d'Izarny-Gargas T; Durrbach A; Zaidan M
    Am J Transplant; 2020 Sep; 20(9):2457-2465. PubMed ID: 32027461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and transplantation-Data censoring.
    Subramanian V; Anderson C; Karp S; Pastan S; Gerber D; Locke J; Cohen A; Shah M; Casingal V; Strata R; Singh N; DuBay D; Dhanireddy K
    Am J Transplant; 2022 Aug; 22(8):1958-1962. PubMed ID: 35451211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five-tier utility: A start on the path to better reporting, in response to Schold and Buccini.
    Wey A; Salkowski N; Kasiske BL; Skeans M; Schaffhausen CR; Gustafson SK; Israni AK; Snyder JJ
    Am J Transplant; 2019 Feb; 19(2):608-609. PubMed ID: 30230203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.